US Patent 9585874 Nuclear transport modulators and uses thereof

Patent 9585874 was granted and assigned to Karyopharm Therapeutics Inc. on March, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9585874

Date of Patent

March 7, 2017

Patent Application Number

14989377

Date Filed

January 6, 2016

Patent Citations Received

‌

US Patent 11945794 Nuclear transport modulators and uses thereof

‌

US Patent 11746102 Polymorphs of selinexor

‌

US Patent 11753401 Polymorphs of Selinexor

‌

US Patent 11787771 Hydrazide containing nuclear transport modulators and uses thereof

Patent Primary Examiner

‌

Rebecca Anderson

Patent abstract

The present invention relates to compounds of formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9585874 Nuclear transport modulators and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API